← Back to Search

Skin Cancer Screening Training for Skin Cancer (SCSES Trial)

N/A
Waitlist Available
Led By Lynne H Robertson, MD, FRCPC
Research Sponsored by Association of Dermatological Prevention, Germany
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 6 years (2012-2018)
Awards & highlights

SCSES Trial Summary

The overall aim of this population-based screening study is to assess whether the skin cancer screening training of family physicians and dermatologists leads to improved screening outcomes. The training course aims to increase the accuracy of detecting early stages of skin cancer. Screening outcomes of an intervention region (Calgary, Canada) in which physicians receive training will be compared with screening outcomes of a control region (Edmonton, Canada) where no physician training is administered. The investigators will determine whether: clinical screening outcomes are more favorable in the group of trained physicians compared to non trained physicians there is an increase of knowledge about skin cancer screening among trained physicians, compared to non trained physicians skin cancer screenings are associated with psycho-social harms population-based screening has an effect on the overall incidence and stage-specific-incidence of skin cancer in Alberta The investigators are aiming to recruit 100 physicians per region (total of 200 physicians) who will screen 40,000 to 80,000 individuals over a period of 20 months.

Eligible Conditions
  • Skin Cancer
  • Melanoma
  • Basal Cell Carcinoma
  • Squamous Cell Carcinoma

SCSES Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 6 years (2012-2018)
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 6 years (2012-2018) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in the diagnostic accuracy including knowledge on skin cancer screening
Number needed to screen (NNS) to identify 1 skin tumor and number needed to excise (NNE) to identify 1 skin tumor
Patient-rated well-being
+1 more

SCSES Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Skin Cancer Screening TrainingExperimental Treatment1 Intervention
Recruited family physicians and dermatologists in Calgary, Canada, take part in a 5.5-hour face-to-face skin cancer screening training program. Screening for skin cancer will be conducted by trained physicians according to instructions they received in the training program.
Group II: No Skin Cancer Screening TrainingActive Control1 Intervention
Recruited family physicians and dermatologists in Edmonton, Canada, WILL BE TRAINED AFTER THE SCREENING PHASE, i.e. during the screening phase non-trained physicians will carry out skin cancer screenings according to standard medical practice.

Find a Location

Who is running the clinical trial?

Association of Dermatological Prevention, GermanyLead Sponsor
University of CalgaryOTHER
791 Previous Clinical Trials
868,621 Total Patients Enrolled
University of AlbertaOTHER
886 Previous Clinical Trials
384,665 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~11 spots leftby Apr 2025